Output Explorer

Trimegestone - Publication and Abstract Tracking Report
7/17/2003
continued Manuscripts - Premarin/TMG
Authors
Priority Article title
Journal
Timing
Status
Jtian W,
A3
300-US QOL - Final data analysis 1) JAMA
In
(3-28-03) Diane Harrison to contact authors for participation
Coney P-J,
development (3-31-03) Joel Bobula has a draft in preparation and will continue
Harrison D,
2)
by Joe
developing it
Pinkerton J,
Obstetrics Bobula of
(6-3-03) Draft circulated for review
Bobula J
Wyeth
Gynecology
NA
B
300-US Lipid and Metabolic data -
(3-28-03) These results to be rolled into the lead paper and thus this
Final data analysis
is not being pursued as a separate paper
5-7-03) Because of promotional needs, this paper will be
resurrected, as the lead paper cannot include the metabolic data
5-29-05) Paper on hold again if data can be incorporated in to the
lead paper
NA
NA
(300-US Basic Efficacy and Safety
(3-5-03) With the full data available, the preliminary analysis should
data - 1 year Interim Analysis)
not be published
Page 7 of 13
Design Write, Inc.
Confidential Pursuant to Confidentiality Order
WINNR201-013982
Source: https://www.industrydocuments.ucsf.edu/docs/yxvw0217

Answer the question using only the OCR text from a single document page. Return only the answer, with no explanation. Preserve the answer wording from the OCR text when possible.